How is AI Influencing Rare Disease Treatments? [David Fajgenbaum] - with Dr. Sanjay Juneja

Video Description

AI is reshaping rare disease treatments by accelerating drug repurposing, identifying therapeutic opportunities, and unlocking actionable insights hidden in clinical data. Discover how innovative frameworks and technology platforms are helping healthcare leaders, diagnostic companies, and telehealth providers uncover new treatment pathways faster and more efficiently. For a summary and key takeaways, visit: https://xcures.com/ai-and-healthcare/highlights/ai-rare-disease-drug-repurposing/ Dr. Sanjay Juneja (https://sjunejamd.com/) speaks with Dr. David Fajgenbaum (https://www.linkedin.com/in/davidfajgenbaum) about the ethical imperative of using AI-driven drug repurposing to address underserved rare conditions and the growing potential to surface overlooked therapies. Gain practical insights on decision-making, data analysis, and scalable solutions that can impact patient care. - - - -TimeStamps - - - - 00:00 Introduction 00:08 The Role of AI in Rare Disease Treatment 01:05 Moral Obligations and Societal Responsibilities #treatment #artificialintelligence #aiandhealthcare #patientcare 📌Watch now to understand how AI-powered strategies can transform how your organization approaches complex diseases. — ABOUT DR. SANJAY JUNEJA — Dr. Sanjay Juneja, a hematologist and medical oncologist widely recognized as “TheOncDoc,” is a trailblazer in healthcare innovation and a rising authority on the transformative role of AI in medicine. Garnering over 750k followers and 20 million views on social media, Dr. Juneja’s unique ability to simplify complex topics has earned him global acclaim. His debut podcast, Target Cancer: Podcast, amassed over 3 million downloads in more than 100 countries within just two years, setting the stage for his current AI-focused series featuring world-renowned guests. He currently serves as the VP of Clinical AI Operations at Tempus AI. https://www.linkedin.com/in/sanjayjunejamd/ — ABOUT DAVID FAJGENBAUM — David Fajgenbaum, MD, MBA, MSc, is a physician-scientist at the University of Pennsylvania and one of the youngest professors to receive tenure in the history of Penn Medicine, co-Founder & President of the Castleman Disease Collaborative Network (CDCN), co-Founder & President of Every Cure, and national bestselling author of ‘Chasing My Cure: A Doctor’s Race to Turn Hope Into Action‘. He is also a patient battling a deadly disease which he discovered a repurposed treatment for that is saving his life and others. Through his work at the University of Pennsylvania’s Center for Cytokine Storm Treatment & Laboratory, CDCN, and Every Cure, he has identified and/or advanced 16 other treatments for diseases they weren’t initially intended for. https://en.wikipedia.org/wiki/David_Fajgenbaum Additional listening channels, at xcures.com/ai-and-healthcare Views expressed by Dr. Juneja, Mr Newton, and guests are solely their own and are not attributable to xCures, Tempus, or any of our guests' affiliations.